Literature DB >> 26614005

Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients.

Debottam Bandyopadhyay1, Sanjay Bandyopadhyay1, Parasar Ghosh2, Abhishek De3, Anupam Bhattacharya4, G K Dhali1, Kshaunish Das5.   

Abstract

BACKGROUND: There is a paucity of reports on extraintestinal manifestations (EIMs) in patients with inflammatory bowel diseases (IBD) from Asia and India.
METHODS: From May 2011 to October 2012, consecutive IBD patients underwent a detailed history and physical examination, also by trained rheumatologist, dermatologist, and ophthalmologist, about whether they experienced any EIM at the time of inclusion or in the past. The disease phenotype/severity and location was classified according to the Montréal classification. All underwent magnetic resonance imaging (MRI) of sacroiliac joints, liver function test (LFT), transabdominal ultrasound, and dual energy X-ray absorptiometry (DEXA) scanning at neck femur (bilateral) and L4-L5 spine.
RESULTS: One hundred twenty patients were analyzed, 62 had Crohn's disease (CD) and 58 had ulcerative colitis (UC). Thirty-eight percent had at least one while 20% suffered from multiple EIMs. Except for uveitis and episcleritis, the frequency of individual EIMs did not differ between CD and UC patients. Twenty-three percent had peripheral arthritis, 18% had ankylosing spondylitis, and 13% had ophthalmological manifestations. Mucocutaneous manifestations, aphthous stomatitis and pyoderma gangrenosum (PG), were seen in 9%. None had erythema nodosum (EN) or primary sclerosing cholangitis (PSC). Fifty percent of patients had either osteopenia or osteoporosis on DEXA. Multivariable analysis revealed female gender, Hindu religion, severe disease, and steroid usage were significantly associated with the presence of EIMs.
CONCLUSION: The prevalence of EIM is similar to that reported from Europe and USA, albeit higher than that previously reported in Asian patients. Female sex, religion, severe disease, and steroid use were associated with EIM.

Entities:  

Keywords:  Liver disease; Spondyloarthritis; Surgery; Tuberculosis

Mesh:

Year:  2015        PMID: 26614005     DOI: 10.1007/s12664-015-0598-8

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  44 in total

1.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

Review 2.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Extraintestinal manifestations of idiopathic ulcerative colitis.

Authors:  R Kochhar; S K Mehta; B Nagi; V Bhatia; M K Goenka; A K Malik
Journal:  Indian J Gastroenterol       Date:  1991-07

4.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

5.  Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center.

Authors:  Stefano Bargiggia; Giovanni Maconi; Marco Elli; Paola Molteni; Sandro Ardizzone; Fabrizio Parente; Ivan Todaro; Salvatore Greco; Guendalina Manzionna; Gabriele Bianchi Porro
Journal:  J Clin Gastroenterol       Date:  2003 May-Jun       Impact factor: 3.062

6.  The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications.

Authors:  J Satsangi; M S Silverberg; S Vermeire; J-F Colombel
Journal:  Gut       Date:  2006-06       Impact factor: 23.059

7.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

8.  Extraintestinal manifestations of idiopathic ulcerative colitis in northwestern India.

Authors:  R K Pokharna; P K Kabra; Rajneesh Sharma; D K Kochar
Journal:  Indian J Gastroenterol       Date:  2004 May-Jun

Review 9.  Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature.

Authors:  D K Christodoulou; K H Katsanos; M Kitsanou; C Stergiopoulou; J Hatzis; E V Tsianos
Journal:  Dig Liver Dis       Date:  2002-11       Impact factor: 4.088

10.  The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients.

Authors:  S Leclerc-Jacob; G Lux; A C Rat; V Laurent; A Blum; I Chary-Valckenaere; L Peyrin-Biroulet; D Loeuille
Journal:  Aliment Pharmacol Ther       Date:  2014-03-04       Impact factor: 8.171

View more
  16 in total

Review 1.  Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.

Authors:  Wendy A Goodman; Ian P Erkkila; Theresa T Pizarro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-09-08       Impact factor: 46.802

Review 2.  Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy.

Authors:  Alana Nevares; Robert Raut; Bonita Libman; Rula Hajj-Ali
Journal:  Curr Rheumatol Rep       Date:  2020-03-26       Impact factor: 4.592

Review 3.  Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.

Authors:  Saurabh Kedia; Vineet Ahuja
Journal:  Inflamm Intest Dis       Date:  2017-04-08

Review 4.  Changing epidemiological trends of inflammatory bowel disease in Asia.

Authors:  Wee Khoon Ng; Sunny H Wong; Siew C Ng
Journal:  Intest Res       Date:  2016-04-27

Review 5.  Ophthalmic manifestations in patients with inflammatory bowel disease: A review.

Authors:  Leandro Lopes Troncoso; Ana Luiza Biancardi; Haroldo Vieira de Moraes; Cyrla Zaltman
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

6.  Pulmonary dysfunction in 114 patients with inflammatory bowel disease.

Authors:  Yujie Zhao; Junshan Wang; Zhanju Liu; Hui Lin; Yanhong Shi; Xiaomin Sun
Journal:  Medicine (Baltimore)       Date:  2017-05       Impact factor: 1.889

7.  Paediatric Inflammatory Bowel Disease: Clinical Presentation and Disease Location.

Authors:  Danish Abdul Aziz; Maryum Moin; Atif Majeed; Kamran Sadiq; Abdul Gaffar Biloo
Journal:  Pak J Med Sci       Date:  2017 Jul-Aug       Impact factor: 1.088

8.  The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.

Authors:  Aimee Hiller; Luc Biedermann; Nicolas Fournier; Matthias Butter; Stephan R Vavricka; Adrian Ciurea; Gerhard Rogler; Michael Scharl
Journal:  PLoS One       Date:  2019-04-30       Impact factor: 3.240

9.  Risk of inflammatory bowel disease in uveitis patients: a population-based cohort study.

Authors:  Tzu-Chen Lo; Yu-Yen Chen; Hsin-Hua Chen
Journal:  Eye (Lond)       Date:  2021-06-21       Impact factor: 4.456

10.  Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients.

Authors:  Bo Ram Yang; Nam-Kyong Choi; Mi-Sook Kim; Jaeyoung Chun; Sang Hyun Joo; Hyesung Kim; Joongyub Lee
Journal:  PLoS One       Date:  2018-07-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.